Employers & Consultants

Line Art 1
Line Art 2
Line Art 3
Line Art 4

Prescryptive Health Partners with Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing

The new financial model aims to provide price transparency while encouraging medication adherence.

Pharmacy benefits: 3 questions to ask to reduce plan costs

Asking these three questions about your pharmacy benefits plan can lead to bigger savings and a better member…

As Seen In: Healthcare Americana

PODCAST: Prescryptive’s Chris Blackley on Prescription Drug Market Transparency

Prescryptive CEO, Chris Blackley, joins the Healthcare Americana podcast to discuss the root of the prescription drug pricing…

Transcarent Selects Prescryptive Health to Power a New, Different and Better Integrated Pharmacy Experience

Partnership will offer a comprehensive and transparent experience for Transcarent Members.

As Seen In: BenefitsPRO

IRA means increased drug prices for commercial plans: Ways to prepare

Drug prices for commercial health plans could increase under the recently passed Inflation Reduction Act. HR must act…

As Seen In: MedCity News

Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it?

Our CEO Chris Blackley writes in MedCity News about the FTC’s new probe into the big pharmacy benefit…

As Seen In: Forbes

Drug Price Transparency Stymies Consumers, New Survey Shows

As Deb Gordon writes in Forbes about our Pharmacy Trends survey, “…90% of survey respondents said they would appreciate…

As Seen In: BenefitsPRO

3 reasons why owning your pharmacy benefits data matters

Owning your pharmacy benefits data is a must. In her latest Benefits PRO article, Andrea Pickett, Prescryptive’s Chief…

As Seen In: Becker's Payer Issue

How to launch a PBM, Mark Cuban style

“With his name, brand and reputation, it has created a lot of interest and appropriately put a brighter…

As Seen In: Becker's Payer Issue

“They’re now exposed”: What an FTC probe, federal legislation, and state actions could mean for the PBM industry

Hear what our co-founder and CEO, Chris Blackley, has to say about the recent FTC probe into the…

As Seen In: BenefitsPRO

Prescription benefits: 3 things you should be discussing with your PBM consultant

Keep reading in Benefits PRO: Prescription benefits: 3 things you should be discussing with your PBM consultant

As Seen In: MedCity News

Why the FTC’s recent decision to not study PBMs might hurt consumers and independent pharmacies – MedCity News

Why the FTC’s recent decision to not study PBMs might hurt consumers and independent pharmacies – MedCity News